AbbVie buys neuroscience drug developer Cerevel Therapeutics for $8.7 billion
American pharmaceutical company AbbVie announced on the purchase of neurological drug developer Cerevel Therapeutics. AbbVie will pay $45 for each...
American pharmaceutical company AbbVie announced on the purchase of neurological drug developer Cerevel Therapeutics. AbbVie will pay $45 for each...
Neuroscience, artificial intelligence and sustainable development - Kommersant Style tells what directions the fragrance industry is moving in. The house...